Clinuvel Pharmaceuticals Limited Share Price Xetra
Stocks
UR9
AU000000CUV3
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
08:12:25 13/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5.789 EUR | 0.00% |
|
0.00% | - |
| Market Cap | 48Cr 34Cr 29Cr 28Cr 25Cr 47Cr 3.23TCr 323.61Cr 126.5Cr 1.62TCr 127.26Cr 124.49Cr 5.4TCr | P/E 2026 * |
13.4x | P/E 2027 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 23Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.53TCr 152.92Cr 60Cr 764.91Cr 60Cr 59Cr 2.55TCr | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 1.86x |
| Free-Float |
83.79% | Yield 2026 * |
0.64% | Yield 2027 * | 0.84% |
Last Transcript: Clinuvel Pharmaceuticals Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 63 | 01/11/2005 |
Peter Vaughan
DFI | Director of Finance/CFO | 42 | 30/06/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karen Agersborg
BRD | Director/Board Member | - | 29/01/2018 |
Susan Smith
BRD | Director/Board Member | - | 23/09/2019 |
| Chairman | - | 01/01/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 34Cr | |
| +0.97% | +4.27% | +43.36% | -0.41% | 7.97TCr | |
| +0.97% | +4.90% | -0.37% | +26.99% | 5.06TCr | |
| -0.86% | -2.27% | +15.55% | +167.71% | 4.88TCr | |
| -0.66% | +5.25% | -47.97% | -48.32% | 4.69TCr | |
| +0.56% | +1.74% | +55.24% | -23.05% | 3.09TCr | |
| +2.43% | +20.31% | +140.98% | -35.20% | 2.54TCr | |
| -0.31% | +1.78% | +40.35% | +84.69% | 2.45TCr | |
| -0.42% | +5.37% | +8.99% | +187.03% | 2.12TCr | |
| -1.06% | -0.24% | +63.96% | +161.82% | 1.64TCr | |
| Average | +0.16% | +3.36% | +35.57% | +57.92% | 3.83TCr | |
| Weighted average by Cap. | +0.28% | +2.91% | +27.47% | +41.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.92Cr 7.02Cr 6.08Cr 5.7Cr 5.2Cr 9.77Cr 669.45Cr 67Cr 26Cr 335.2Cr 26Cr 26Cr 1.12TCr | 10Cr 7.4Cr 6.41Cr 6.01Cr 5.48Cr 10Cr 705.87Cr 71Cr 28Cr 353.44Cr 28Cr 27Cr 1.18TCr |
| Net income | 3.57Cr 2.53Cr 2.19Cr 2.05Cr 1.87Cr 3.52Cr 241.03Cr 24Cr 9.43Cr 120.69Cr 9.49Cr 9.28Cr 402.43Cr | 3.77Cr 2.66Cr 2.31Cr 2.16Cr 1.97Cr 3.71Cr 254.14Cr 25Cr 9.94Cr 127.25Cr 10Cr 9.79Cr 424.31Cr |
| Net Debt | -25Cr -18Cr -15Cr -15Cr -13Cr -25Cr -1.71TCr -170.69Cr -67Cr -853.81Cr -67Cr -66Cr -2.85TCr | -28Cr -20Cr -17Cr -16Cr -15Cr -28Cr -1.92TCr -192.25Cr -75Cr -961.63Cr -76Cr -74Cr -3.21TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
Select your edition
All financial news and data tailored to specific country editions
